US Stem Cell Inc (USRM)

[Zues]

We have a small cap biotech company here that has a potential breakthrough product in Myocell.

325mm O/S.

Growing revenue stream.

Low overhead.

Positive cash flow.

Multiple new clinic openings (to include Texas) in support of ASCCOE/GACP.

Partnership with ASCCOE = revenue stream.

Texas RTT law 9/01.

Other states will most likely follow Texas.

Federal RTT Law to be signed by POTUS.

Established RMAT guidelines post 9/01 (relevant only if USRM renews their effort to obtain RMAT which I expect them to).

All this for a measly .03 s/p. Crazy.

I spy another small cap biotech that does not have growing revenues. Is not cash positive. Hasn't even completed phase 1/2 trails and is heading for a R/S. This stock trades above .07...:)

LOL